Literature DB >> 17898191

Exceeding the limits of the normal blood-brain barrier: quo vadis gadolinium?

L M Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17898191      PMCID： PMC8134245          DOI： 10.3174/ajnr.A0725

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  7 in total

Review 1.  Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease?

Authors:  Ryszard Pluta
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

2.  What is right about MRI permeability studies.

Authors:  Lucien M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

3.  [Sequential changes in magnetic resonance in a limbic status epilepticus].

Authors:  F Villalobos-Chávez; J J Rodríguez-Uranga; G Sanz-Fernández
Journal:  Rev Neurol       Date:  2005 Mar 16-31       Impact factor: 0.870

4.  Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation.

Authors:  Eung Yeop Kim; Sam Soo Kim; Dong Gyu Na; Hong Gee Roh; Jae Wook Ryoo; Ho Kyun Kim
Journal:  J Comput Assist Tomogr       Date:  2005 Mar-Apr       Impact factor: 1.826

5.  Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation.

Authors:  A C Mamourian; P J Hoopes; L D Lewis
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

6.  Gadolinium encephalopathy in a patient with renal failure.

Authors:  Boby Varkey Maramattom; Edward M Manno; Eelco F M Wijdicks; Edward P Lindell
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.

Authors:  E A van Vliet; S da Costa Araújo; S Redeker; R van Schaik; E Aronica; J A Gorter
Journal:  Brain       Date:  2006-11-22       Impact factor: 13.501
  7 in total
  4 in total

1.  Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.

Authors:  G Orman; K Y Wang; Y Pekcevik; C B Thompson; M Mealy; M Levy; I Izbudak
Journal:  AJNR Am J Neuroradiol       Date:  2017-03-16       Impact factor: 3.825

Review 2.  What do we know about brain contrast enhancement patterns in neuromyelitis optica?

Authors:  Yeliz Pekcevik; Gunes Orman; In Ho Lee; Maureen A Mealy; Michael Levy; Izlem Izbudak
Journal:  Clin Imaging       Date:  2015-07-26       Impact factor: 1.605

3.  Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.

Authors:  Achmad Adhipatria Perayabangsa Kartamihardja; Hirofumi Hanaoka; Putri Andriana; Satomi Kameo; Ayako Takahashi; Hiroshi Koyama; Yoshito Tsushima
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

4.  Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.

Authors:  Jessica Lohrke; Anna-Lena Frisk; Thomas Frenzel; Laura Schöckel; Martin Rosenbruch; Gregor Jost; Diana Constanze Lenhard; Martin A Sieber; Volker Nischwitz; Astrid Küppers; Hubertus Pietsch
Journal:  Invest Radiol       Date:  2017-06       Impact factor: 6.016
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.